Im a nuclear medicine student and have had a bit of first hand experience on clinicals, using technegas to look for PE. In my opinion it doesn't matter what price you get in on, because when CYC get FDA approval (i cannot see why they wouldnt with peer reviewed proven higher sensitivity, specificity with a lower radiation dose) the SP will sky rocket.
If technegas becomes a regular accepted diagnostic tool with COPD then not even the sky is the limit. And all holders will be sitting on a gold mine.
As long as all goes according to schedule, bring on 2018
Im a nuclear medicine student and have had a bit of first hand...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.00 |
Change
0.005(0.50%) |
Mkt cap ! $111.1M | |||
| Open | High | Low | Value | Volume |
| $1.00 | $1.04 | $1.00 | $215.2K | 211.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10089 | 99.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.04 | 3762 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| CYC (ASX) Chart |